Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $402.49, representing a -1.13% change from its previous close.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Artivion, Inc. AORT: This medical device and tissue ...

Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s ...

The artificial intelligence (AI) boom has taken the stock market by storm. The S&P 500 (SNPINDEX: ^GSPC) has advanced 55% in ...

After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

Like its competitors, Google continues to experiment with low- and no-code tools that harness agentic AI for business ...

Fintel reports that on January 3, 2025, Raymond James downgraded their outlook for Vertex (NasdaqGM:VERX) from Outperform to ...

Google's groundbreaking white paper reveals how AI agents leverage advanced reasoning, real-time data access and autonomous decision-making.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Arish Global Services, the all-in-one solution for web lead generation based in the UK, announced today its partnership with Vertex Global Services ...

PYCR shares rise on revenue growth projections, product innovations, and strong demand in HCM and payroll solutions.